Sec23IP recruits VPS13B/COH1 to ER exit site–Golgi interface for tubular ERGIC formation
Journal of Cell Biology · 2024
DOI: 10.1083/jcb.202402083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Yuanjiao Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatme…. Hauptthemen laut MEDLINE: Endoplasmic Reticulum, Golgi Apparatus, Intellectual Disability, Microcephaly. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shenzhen Bay Scholars Program.
Abstract (Originalsprache)
VPS13B/COH1 is the only known causative factor for Cohen syndrome, an early-onset autosomal recessive developmental disorder with intellectual inability, developmental delay, joint hypermobility, myopia, and facial dysmorphism as common features, but the molecular basis of VPS13B/COH1 in pathogenesis remains largely unclear. Here, we identify Sec23 interacting protein (Sec23IP) at the ER exit site (ERES) as a VPS13B adaptor that recruits VPS13B to ERES–Golgi interfaces. VPS13B interacts directly with Sec23IP via the VPS13 adaptor binding domain (VAB), and the interaction promotes the association between ERES and the Golgi. Disease-associated missense mutations of VPS13B–VAB impair the interaction with Sec23IP. Knockout of VPS13B or Sec23IP blocks the formation of tubular ERGIC, an unconventional cargo carrier that expedites ER-to-Golgi transport. In addition, depletion of VPS13B or Sec23IP delays ER export of procollagen, suggesting a link between procollagen secretion and joint laxity in patients with Cohen disease. Together, our study reveals a crucial role of VPS13B–Sec23IP interaction at the ERES–Golgi interface in the pathogenesis of Cohen syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Scie…
- Shenzhen Bay Laboratory , Shenzhen, China.
- Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Cell Architecture Research Center, Huazhong University of Science and Technology , Wuhan, China.
ORCID-Profile: Yuanjiao Du, Xinyu Fan, Chunyu Song, Weiping Chang, Juan Xiong, Lin Deng, Wei-Ke Ji
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shenzhen Bay Scholars Program
Zitieren
APA
Du, Y., Fan, X., Song, C., Chang, W., Xiong, J., Deng, L., & Ji, W. K. (2024). Sec23IP recruits VPS13B/COH1 to ER exit site–Golgi interface for tubular ERGIC formation. Journal of Cell Biology. https://doi.org/10.1083/jcb.202402083
Vancouver
Du Y, Fan X, Song C, Chang W, Xiong J, Deng L, et al. Sec23IP recruits VPS13B/COH1 to ER exit site–Golgi interface for tubular ERGIC formation. Journal of Cell Biology. 2024. doi:10.1083/jcb.202402083
BibTeX
@article{Du2024,
author = {Du, Yuanjiao and Fan, Xinyu and Song, Chunyu and Chang, Weiping and Xiong, Juan and Deng, Lin and Ji, Wei-Ke},
title = {Sec23IP recruits VPS13B/COH1 to ER exit site–Golgi interface for tubular ERGIC formation},
journal = {Journal of Cell Biology},
year = {2024},
doi = {10.1083/jcb.202402083}
}
EUVIMED